Bank of Hawaii’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,095
Closed -$408K 302
2020
Q1
$408K Sell
4,095
-135
-3% -$17.5K 0.04% 214
2019
Q4
$631K Buy
4,230
+1,025
+32% +$139K 0.04% 215
2019
Q3
$411K Buy
3,205
+70
+2% +$9.38K 0.03% 258
2019
Q2
$447K Buy
+3,135
New +$421K 0.03% 247

Other funds holding JAZZ

Bank of Hawaii's JAZZ Position: Q2 2020 in Review

Bank of Hawaii sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 4,095 shares — an estimated $408K sold.

Bank of Hawaii first reported a position in JAZZ in Q2 2019 and held it in 4 quarters. The position peaked at $631K in Q4 2019. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • Bank of Hawaii reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Bank of Hawaii sold 4,095 Jazz Pharmaceuticals shares in Q2 2020, an estimated $408K.
  • Bank of Hawaii first reported a position in Jazz Pharmaceuticals in Q2 2019 and held it in 4 quarters.
  • Bank of Hawaii's Jazz Pharmaceuticals position peaked at $631K in Q4 2019.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Bank of Hawaii's 13F filing for Q2 2020, filed 14 Aug 2020.